H.Res. 531 · 112th Congress
Recognizing the 40th anniversary of the National Cancer Act of 1971 and the more than 12,000,000 survivors of…
Full title
Recognizing the 40th anniversary of the National Cancer Act of 1971 and the more than 12,000,000 survivors of cancer alive today because of the commitment of the United States to cancer research and advances in cancer prevention, detection, diagnosis, and treatment.
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 112th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
42 cosponsors · 38 D, 4 R
39 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
Recognizes the 40th anniversary of the National Cancer Act of 1971.
What it does: CRS summary · Introduced in House · Jan 31, 2012
Recognizes the 40th anniversary of the National Cancer Act of 1971.
Reaffirms that support for cancer research continues to be a national priority.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Recognizing the 40th anniversary of the National Cancer Act of 1971 and the more than 12,000,000 survivors of cancer alive today because of the commitment of the United States to cancer research and advances in cancer prevention, detection, diagnosis, and treatment.
Latest action (Jan 31, 2012): Referred to the House Committee on Energy and Commerce.
Policy area: Health · Origin: House · Introduced: Jan 31, 2012
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.